Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2016

May 3, 2016

35221_dirs_2016-05-02_03b422e4-8aff-45c5-a880-868d6e0613da.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2016-04-28

Reporting Person: Greenspan Ira Scott (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-04-28 Common Stock A 87020 Acquired 87020 Indirect
2016-04-28 Common Stock A 125000 Acquired 125000 Indirect
2016-04-28 Common Stock A 20000 Acquired 20000 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-04-28 Warrants $5.00 A 87020 Acquired 2022-01-29 Common Stock (87020) Indirect
2016-04-28 Warrants $5.00 A 125000 Acquired 2022-01-29 Common Stock (125000) Indirect
2016-04-28 Warrants $5.00 A 20000 Acquired 2022-01-29 Common Stock (20000) Indirect
2016-04-28 Employee Stock Option (Right to Buy) $5.00 A 97554 Acquired 2026-04-28 Common Stock (97554) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 27873 Direct
Common Stock 5713879 Indirect
Common Stock 20904 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Warrants $5.00 2022-01-29 Common Stock (27873) 27873 Direct
Warrants $5.00 2022-01-29 Common Stock (5713879) 5713879 Indirect
Warrants $5.00 2022-01-29 Common Stock (6968) 6968 Indirect

Footnotes

F1: Mr. Greenspan is a member and a co-manager of HCFP/Capital Partners III LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.

F2: Robert M. Greenspan is the reporting person's son.

F3: The reporting person purchased units from the issuer, each unit consisting of one share of the issuer's common stock and one warrant, at a price of $5.00 per unit. Each warrant entitles the holder to purchase one share of the issuer's common stock at an exercise price of $5.00 per share, subject to adjustment.

F4: Mr. Greenspan is a controlling shareholder of HCFP Inc., and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his proportionate pecuniary interest therein.

F5: Mr. Greenspan is a member and a co-manager of the entity that acts as sole manager of HCFP/Capital Partners IIIB LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.

F6: Mr. Greenspan is a co-manager of HCFP/AG LLC, and shares joint voting and dispositive power over the shares held by this entity. Mr. Greenspan disclaims beneficial ownership of shares held by this entity, except to the extent of his pecuniary interest therein.

F7: The option vests as to 3/36 of the shares on July 28, 2016 and in 33 equal monthly installments thereafter.